Journal of Clinical Endocrinology & Metabolism, Vol 72, 862-866, Copyright © 1991 by Endocrine Society

ARTICLES

Circulating bioactive inhibin levels during human pregnancy

JP Qu, L Vankrieken, C Brulet and K Thomas
Department of Obstetrics and Gynecology, University of Louvain, Brussels, Belgium.

In this study bioactive inhibin was measured in 112 serum samples from 103 pregnant women by a sensitive ovine pituitary cell culture system. Human inhibin activities were detected in a range between 0.02-5.28 U/mL at six dilutions by using serum from the 38-week pregnant women as a quality control. A remarkable increase in serum inhibin was observed from 4 to 38 weeks of pregnancy. The mean serum inhibin level was 1.58 U/mL at 4 weeks. Thereafter, inhibin levels increased progressively with the weeks of pregnancy (r = 0.988; P less than 0.001). In the midterm of pregnancy, serum inhibin was elevated at average levels of 2.84 and 3.84 U/mL at 20 and 28 weeks, respectively. The peak level of inhibin (5.33 U/mL) was obtained at 38 weeks, which was an increase of 237% compared to that at 4 weeks. The average rate of increase in serum inhibin levels was 14.51% every 2-4 weeks (ranging from 8.1-20%). These findings suggest that circulating inhibin is useful marker during human pregnancy.

This article has been cited by other articles:

				E. M. Wallace, S. C. Riley, J. A. Crossley, S. C. Ritoe, A. Horne, M. Shade, P. M. Ellis, D. A. Aitken, and N. P. Groome Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 218 - 222. [Abstract] [Full Text] [PDF]

				D. A. Aitken, E. M. Wallace, J. A. Crossley, I. A. Swanston, Y. van Pareren, M. van Maarle, N. P. Groome, J. N. Macri, and J. M. Connor Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy N. Engl. J. Med., May 9, 1996; 334(19): 1231 - 1236. [Abstract] [Full Text] [PDF]